Skip to content

Drug interactions

Dexlansoprazole + Idelalisib

Severity: Minor

Dexlansoprazole and Idelalisib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Idelalisib is a strong CYP3A inhibitor and may increase dexlansoprazole concentrations. Dexlansoprazole has a wide safety margin, so the increase is rarely harmful. The caution for sensitive CYP3A substrates mainly concerns narrow-therapeutic-index drugs.

What this interaction means in plain words

Dexlansoprazole and Idelalisib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dexlansoprazole belongs to Gastrointestinal Tract; Idelalisib belongs to Oncology.

Evidence level: Low

Why it happens

Strong CYP3A inhibition by idelalisib decreasing dexlansoprazole metabolism.

What to do

No dose change is usually necessary. Monitor for PPI adverse effects during prolonged high-dose use.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dexlansoprazole and Idelalisib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dexlansoprazole with Idelalisib?

MediHelp rates the interaction as minor. Dexlansoprazole and Idelalisib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Idelalisib is a strong CYP3A inhibitor and may increase dexlansoprazole concentrations. Dexlansoprazole has a wide safety margin, so the increase is rarely harmful. The caution for sensitive CYP3A substrates mainly concerns narrow-therapeutic-index drugs.

How serious is the interaction between Dexlansoprazole and Idelalisib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually necessary. Monitor for PPI adverse effects during prolonged high-dose use.

What other medicines interact with Dexlansoprazole?

MediHelp also lists interactions of Dexlansoprazole with, for example, Mavacamten, Rilpivirine, Acalabrutinib. The full list is on the Dexlansoprazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in